Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group.
Publication/Presentation Date
3-1-2020
Abstract
Survivorship care for patients with prostate cancer requires careful consideration of unique disease-specific factors, including the prolonged natural disease history, the potential for competing health risks, and the consequences of long-term androgen deprivation therapy. However, current prostate cancer survivorship research is unfortunately limited by the lack of a robust supportive evidence base, variability in the definitions and measurement of survivorship outcomes, and a heavy reliance on expert opinion. As a result, the conduct of quality prostate cancer survivorship research is of increasing importance for patients, medical providers, and other key stakeholders. This manuscript harmonizes a path forward for improving prostate cancer survivorship by defining prostate cancer survivorship and survivorship research, as well as by highlighting key research priorities and cooperative mechanisms for survivorship studies within prostate cancer, with a particular focus on men with advanced disease.
Volume
38
Issue
3
First Page
83
Last Page
93
ISSN
1873-2496
Published In/Presented At
Narayan, V., Harrison, M., Cheng, H., Kenfield, S., Aggarwal, R., Kwon, D., McKay, R., Hauger, R., Hart, N., Conzen, S., Borno, H., Jim, H., Dicker, A., Dorff, T., Moslehi, J., Mucci, L., Parsons, J. K., Saad, F., Soule, H., Morgans, A., … Ryan, C. J. (2020). Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group. Urologic oncology, 38(3), 83–93. https://doi.org/10.1016/j.urolonc.2019.10.006
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
31734020
Department(s)
Administration and Leadership
Document Type
Article